Rocket Pharmaceuticals In... (RCKT)
10.89
0.46 (4.41%)
At close: Jan 15, 2025, 1:44 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -245.59M | -221.86M | -169.07M | -139.70M | -77.27M | -74.52M | -29.50M | -42.85M | -67.98M | -9.53M | -7.62M | -6.06M |
| Depreciation & Amortization | 7.10M | 6.27M | 5.37M | 1.15M | 426.00K | 330.00K | 200.00K | 169.00K | 45.00K | n/a | n/a | 9.00K |
| Stock-Based Compensation | 39.41M | 31.01M | 29.24M | 18.57M | 13.37M | 13.60M | 4.04M | 2.91M | 2.38M | 177.00K | -148.00K | 486.00K |
| Other Working Capital | 13.46M | -3.60M | 1.44M | 4.01M | -1.00M | -1.50M | -886.00K | 2.16M | 182.00K | -2.39M | 894.00K | -1.75M |
| Other Non-Cash Items | -9.28M | 370.00K | 13.53M | 29.32M | 3.60M | 2.90M | 522.00K | 162.00K | 1.11M | 1.08M | 573.00K | 213.00K |
| Deferred Income Tax | n/a | n/a | 3.15M | 999.00K | -1.07M | -484.00K | 654.00K | 225.00K | 46.36M | n/a | n/a | 2.00K |
| Change in Working Capital | 13.46M | 6.08M | -3.39M | 15.03M | -3.73M | 4.38M | -2.03M | 2.12M | 669.00K | -1.47M | 736.00K | -1.59M |
| Operating Cash Flow | -194.92M | -178.14M | -121.16M | -74.64M | -64.66M | -53.79M | -26.11M | -37.27M | -17.42M | -9.74M | -6.46M | -6.94M |
| Capital Expenditures | -16.47M | -8.62M | -7.71M | -29.06M | -23.27M | -1.45M | -70.00K | -487.00K | -412.00K | n/a | n/a | n/a |
| Acquisitions | n/a | 42.73M | 95.00K | 8.45M | 15.74K | 76.35M | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -390.92M | -376.33M | -245.88M | -209.34M | -184.30M | -141.09M | -27.20M | -122.28M | -33.69M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 309.33M | 272.89M | 272.44M | 141.81M | 168.56M | 61.28M | 102.29M | 56.70M | 2.43M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -103.69K | -95.00K | -8.45M | -15.74K | -356.00K | n/a | n/a | n/a | n/a | n/a | 3.00K |
| Investing Cash Flow | -98.07M | -69.33M | 18.85M | -96.59M | -39.01M | -5.27M | 75.02M | -66.06M | -31.68M | n/a | n/a | 3.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 48.74M | 13.36M | 560.00K | 7.92M | 2.50M |
| Common Stock Repurchased | n/a | -47.00K | n/a | -72.00K | n/a | -668.00K | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 7.00K | n/a | n/a | 1.71M | -313.00K | 148.00K | 19.00K | 346.00K | 106.00K | 8.00K | 9.96M | n/a |
| Financial Cash Flow | 208.40M | 155.29M | 37.68K | 282.99M | 177.79M | 153.50M | 25.41K | 16.00 | 125.52M | 568.00K | 17.88M | 2.50M |
| Net Cash Flow | -84.58M | -92.18M | -64.63M | 111.76M | 74.12M | 94.44M | 48.92M | -50.24M | 76.42M | -9.18M | 11.42M | -4.43M |
| Free Cash Flow | -211.39M | -186.76M | -128.88M | -103.70M | -87.93M | -55.24M | -26.18M | -37.75M | -17.83M | -9.74M | -6.46M | -6.94M |